DETECTION OF EPIDERMAL GROWTH FACTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN COLORECTAL CANCERS
Liu Gl
Abstract
Liu Gl
Abstract
We immunohistochemically examined expression of EGF and EGF-R in 52 colorectal cancer tissues and 18 normal colon tissues. EGF and EGF-R positive rate were 22. 2% and 16. 7% in normal colon tissues,67. 3% and 61. 5% in colorectal cancers, The positive rate of EGF and EGF-R in colorcetal cancer significantly higher than that in normal tissues (P0. 05). the positive rate of EGF and EGF-R in advance cancers were higher than in early stage cancer. Expression of EGF or EGF-R was no relation to age,sex or location of cancer, Our results suggests that part colorectal cancer have overexpression of EGF and EGF-R,EGF and EGF-R autocrine may contribute to the growth of colorectal cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We immunohistochemically examined expression of EGF and EGF-R in 52 colorectal cancer tissues and 18 normal colon tissues. EGF and EGF-R positive rate were 22. 2% and 16. 7% in normal colon tissues,67. 3% and 61. 5% in colorectal cancers, The positive rate of EGF and EGF-R in colorcetal cancer significantly higher than that in normal tissues (P0. 05). the positive rate of EGF and EGF-R in advance cancers were higher than in early stage cancer. Expression of EGF or EGF-R was no relation to age,sex or location of cancer, Our results suggests that part colorectal cancer have overexpression of EGF and EGF-R,EGF and EGF-R autocrine may contribute to the growth of colorectal cancer.
Key concepts: Epidermal growth factor, Colorectal cancer, Autocrine signalling, Epidermal growth factor receptor, Heparin-binding EGF-like growth factor, Cancer, Internal medicine, Cancer research